Nom du produit:1-Methyl-1H-pyrazole-4-sulfonyl chloride
IUPAC Name:1-methyl-1H-pyrazole-4-sulfonyl chloride
- CAS:288148-34-5
- Formule moléculaire:C4H5ClN2O2S
- Pureté:95%+
- Numéro de catalogue:CM188010
- Poids moléculaire:180.61
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:288148-34-5
- Formule moléculaire:C4H5ClN2O2S
- Point de fusion:-
- Code SMILES:O=S(C1=CN(C)N=C1)(Cl)=O
- Densité:
- Numéro de catalogue:CM188010
- Poids moléculaire:180.61
- Point d'ébullition:
- N° Mdl:MFCD04968667
- Stockage:Keep in inert atmosphere, store at 2-8°C.
Category Infos
- Pyrazoles
- Pyrazoles are organic compounds of the general formula C3H3N2H. It is a five-membered heterocycle consisting of three carbon atoms and two adjacent nitrogen atoms. As an H-bond-donating heterocycle, pyrazole has been used as a more lipophilic and metabolically more stable bioisomer of phenol. Pyrazoles have attracted more and more attention due to their broad spectrum of action and strong efficacy.
- Pyrazone
- Custom pyrazone for customers from all over the world are our main business.
Column Infos
- Relacorilant
- Corcept completes enrollment in phase 3 Gradient trial of Relacorilant in patients with Adrenal Cushing’s Syndrome. Cushing's disease or hypercortisolism is a rare endocrine disorder that occurs when a pituitary adenoma makes excessive cortisol. Cortisol exerts its functions by binding to the glucocorticoid receptor (GR).
Relacorilant is a selective glucocorticoid receptor modulator (SGRM) in clinical development to prevent the effects of high cortisol. Relacorilant is being studied in various serious disorders, including ovarian, adrenal and prostate cancer and Cushing’s syndrome.